Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb 29;8(5):1279.
doi: 10.4022/jafib.1279. eCollection 2016 Feb-Mar.

Clinical and Economic Implications of AF Related Stroke

Affiliations
Review

Clinical and Economic Implications of AF Related Stroke

Ali N Ali et al. J Atr Fibrillation. .

Abstract

A major cause of morbidity and mortality among patients with atrial fibrillation (AF) relates to the increased risk of stroke. The burden of illness that AF imparts on stroke is likely to increase with our aging populations and increasingly sophisticated cardiac monitoring techniques. Understanding the clinical and economic differences between AF related ischaemic stroke and non-AF related stroke is important if we are to improve future cost effectiveness analyses of potential preventative treatments, but also to help educate clinical and policy decision makers on use or availability of treatments to prevent AF related stroke. In this article we review the existing evidence that highlights differences in the clinical characteristics and outcomes between AF and non-AF stroke, as well as differences in their economic impact and discuss ways to improve future economic analyses.

Keywords: Atrial Fibrillation; Cost Effectiveness; Costs; Stroke Outcomes.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Miyasaka Yoko, Barnes Marion E, Gersh Bernard J, Cha Stephen S, Bailey Kent R, Abhayaratna Walter P, Seward James B, Tsang Teresa S M. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006 Jul 11;114 (2):119–25. - PubMed
    1. Go A S, Hylek E M, Phillips K A, Chang Y, Henault L E, Selby J V, Singer D E. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001 May 9;285 (18):2370–5. - PubMed
    1. Schnabel Renate B, Yin Xiaoyan, Gona Philimon, Larson Martin G, Beiser Alexa S, McManus David D, Newton-Cheh Christopher, Lubitz Steven A, Magnani Jared W, Ellinor Patrick T, Seshadri Sudha, Wolf Philip A, Vasan Ramachandran S, Benjamin Emelia J, Levy Daniel. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015 Jul 11;386 (9989):154–62. - PMC - PubMed
    1. Patel Nileshkumar J, Deshmukh Abhishek, Pant Sadip, Singh Vikas, Patel Nilay, Arora Shilpkumar, Shah Neeraj, Chothani Ankit, Savani Ghanshyambhai T, Mehta Kathan, Parikh Valay, Rathod Ankit, Badheka Apurva O, Lafferty James, Kowalski Marcin, Mehta Jawahar L, Mitrani Raul D, Viles-Gonzalez Juan F, Paydak Hakan. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning. Circulation. 2014 Jun 10;129 (23):2371–9. - PubMed
    1. Wolf P A, Abbott R D, Kannel W B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991 Aug;22 (8):983–8. - PubMed

LinkOut - more resources